BFM
BSX icon

Boothbay Fund Management’s Boston Scientific BSX Stock Holding History

Boothbay Fund Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-71,800
Closed -$4.51M – 2276
2026
Q1 		$4.51M Buy
+71,800
New +$5.74M 0.06% 347
2022
Q4 		– Sell
-17,900
Closed -$693K – 2025
2022
Q3 		$693K Buy
+17,900
New +$718K 0.02% 1064
2022
Q1 		– Sell
-16,500
Closed -$701K – 2290
2021
Q4 		$701K Buy
+16,500
New +$693K 0.02% 890

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boothbay Fund Management's BSX Position: Q2 2026 in Review

Boothbay Fund Management increased its Boston Scientific (BSX) stake by 107% in Q2 2026, buying an estimated $4.38M and bringing the position to 155,842 shares worth $6.65M. The position accounts for 0.09% of the portfolio, ranked #259.

Boothbay Fund Management first reported a position in BSX in Q3 2015 and has held it in 31 quarters since. The position peaked at $16.6M in Q3 2022. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Boothbay Fund Management held 155,842 shares of Boston Scientific worth $6.65M as of Q2 2026.
  • Boothbay Fund Management bought 80,630 Boston Scientific shares in Q2 2026, an estimated $4.38M.
  • Boston Scientific made up 0.09% of Boothbay Fund Management's portfolio in Q2 2026, its #259 holding.
  • Boothbay Fund Management first reported a position in Boston Scientific in Q3 2015 and has held it in 31 quarters since.
  • Boothbay Fund Management's Boston Scientific position peaked at $16.6M in Q3 2022.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.